General
Preferred name
URIC ACID
Synonyms
uric-acid ()
Uric acid (sodium) ()
Uric acid sodium ()
Monosodium urate ()
Idelalisib metabolite m54 ()
Lithic acid ()
NSC-3975 ()
2,6,8-Trioxypurine ()
Uricum acidum ()
Uric Acid (sodium salt) ()
Uric Acid-13C,15N3 ()
P&D ID
PD008492
CAS
10101-22-1
18276-12-5
13154-20-6
69-93-2
1198-77-2
2421217-23-2
Tags
available
drug candidate
Drug indication
Ischemic stroke
Discovery agent
Drug Status
investigational
Max Phase
2.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Uric acid sodium (Monosodium urate), scavenger of oxygen radical, is a very important antioxidant that help maintains the stability of blood pressure and antioxidant stress. Uric acid sodium can remove reactive oxygen species (ROS) such as singlet oxygen and peroxynitrite, inhibiting lipid peroxidation[1][2].
PRICE 29
DESCRIPTION Uric Acid (Lithic acid) is an oxidation product of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
PRICE 29
DESCRIPTION Uric acid is a ubiquitous end product of purine metabolism in humans that is mainly excreted in urine, whereas in other mammals it is further metabolized to allantoin by uricase. Uric acid is an endogenous antioxidant that scavenges reactive oxygen species (ROS) including singlet oxygen, oxygen radicals, and peroxynitrite. (Enamine Bioactive Compounds)
DESCRIPTION Uric acid sodium, scavengers of oxygen radicals, is a potent and common antioxidant that helps maintain stable blood pressure and resist oxidative stress. Uric acid sodium, which removes reactive oxygen species (ROS) such as singlet oxygen and peroxynitrite, has an inhibitory effect on lipid peroxidation and is associated with the pathogenesis of gout joint disease and the formation of calcium oxalate stones. (TargetMol Bioactive Compound Library)
Compound Sets
16
Cayman Chemical Bioactives
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Concise Guide to Pharmacology 2025/26
Drug Repurposing Hub
DrugBank
DrugMAP
Enamine Bioactive Compounds
Enamine BioReference Compounds
Guide to Pharmacology
MedChem Express Bioactive Compound Library
ReFrame library
TargetMol Bioactive Compound Library
External IDs
115
Properties
(calculated by RDKit )
Molecular Weight
168.03
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
4
Rotatable Bonds
0
Ring Count
2
Aromatic Ring Count
2
cLogP
-1.77
TPSA
114.37
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
6.0
QED
0.37
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
NF-¦ÊB
Immunology/Inflammation
Metabolic Enzyme/Protease
NF-κB
Metabolism
Target
Reactive Oxygen Species
PYGL
Endogenous Metabolite
Environmental Pollutants
Reactive Oxygen Species (ROS)
Source data